DE69306559D1 - Neue kardioprotektive wirkstoffe - Google Patents

Neue kardioprotektive wirkstoffe

Info

Publication number
DE69306559D1
DE69306559D1 DE69306559T DE69306559T DE69306559D1 DE 69306559 D1 DE69306559 D1 DE 69306559D1 DE 69306559 T DE69306559 T DE 69306559T DE 69306559 T DE69306559 T DE 69306559T DE 69306559 D1 DE69306559 D1 DE 69306559D1
Authority
DE
Germany
Prior art keywords
active substances
protective active
cardio protective
new
new cardio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69306559T
Other languages
English (en)
Other versions
DE69306559T2 (de
Inventor
J Grisar
Margaret Petty
Frank Bolkenius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69306559D1 publication Critical patent/DE69306559D1/de
Publication of DE69306559T2 publication Critical patent/DE69306559T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Paints Or Removers (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
DE69306559T 1992-04-06 1993-03-08 Neue kardioprotektive wirkstoffe Expired - Lifetime DE69306559T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92400957 1992-04-06
PCT/US1993/002102 WO1993020058A1 (en) 1992-04-06 1993-03-08 Novel cardioprotective agents

Publications (2)

Publication Number Publication Date
DE69306559D1 true DE69306559D1 (de) 1997-01-23
DE69306559T2 DE69306559T2 (de) 1997-04-10

Family

ID=8211647

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69306559T Expired - Lifetime DE69306559T2 (de) 1992-04-06 1993-03-08 Neue kardioprotektive wirkstoffe

Country Status (18)

Country Link
EP (1) EP0635010B1 (de)
JP (1) JP3248183B2 (de)
KR (1) KR100243820B1 (de)
AT (1) ATE146175T1 (de)
AU (1) AU667889B2 (de)
CA (1) CA2132745C (de)
DE (1) DE69306559T2 (de)
DK (1) DK0635010T3 (de)
ES (1) ES2098030T3 (de)
FI (1) FI112658B (de)
GR (1) GR3022471T3 (de)
HU (1) HU217426B (de)
IL (1) IL105320A (de)
NO (1) NO307088B1 (de)
NZ (1) NZ251131A (de)
TW (1) TW232014B (de)
WO (1) WO1993020058A1 (de)
ZA (1) ZA932326B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions
CN115073413B (zh) * 2022-05-17 2023-06-02 中山大学 一种苯并环醚类倍半萜类化合物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947473A (en) * 1972-12-22 1976-03-30 Hoffman-La Roche Inc. Antioxidant chroman compounds
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs

Also Published As

Publication number Publication date
CA2132745A1 (en) 1993-10-14
WO1993020058A1 (en) 1993-10-14
FI112658B (fi) 2003-12-31
ATE146175T1 (de) 1996-12-15
HU9402863D0 (en) 1995-01-30
ES2098030T3 (es) 1997-04-16
FI944656A0 (fi) 1994-10-05
ZA932326B (en) 1993-10-18
AU3797293A (en) 1993-11-08
EP0635010A1 (de) 1995-01-25
CA2132745C (en) 2000-03-21
NO943727L (no) 1994-12-05
AU667889B2 (en) 1996-04-18
NO307088B1 (no) 2000-02-07
DE69306559T2 (de) 1997-04-10
HUT68982A (en) 1995-08-28
GR3022471T3 (en) 1997-05-31
TW232014B (de) 1994-10-11
IL105320A (en) 1998-02-08
NO943727D0 (no) 1994-10-05
HU217426B (hu) 2000-01-28
JP3248183B2 (ja) 2002-01-21
KR100243820B1 (ko) 2000-03-02
KR950700896A (ko) 1995-02-20
NZ251131A (en) 1996-01-26
JPH07505392A (ja) 1995-06-15
FI944656A (fi) 1994-10-05
IL105320A0 (en) 1993-08-18
DK0635010T3 (da) 1996-12-30
EP0635010B1 (de) 1996-12-11

Similar Documents

Publication Publication Date Title
DE69027865D1 (de) ZUSAMMENSETZUNGEN enthaltend omega Conotoxin Peptide Derivate und deren Verwendung ZUR BEHANDLUNG VON ISCHÄMIE-ARTIGEN NEURONALEN SCHÄDIGUNGEN
ATE194767T1 (de) In liposomen verkapseltes taxol und verwendungsverfahren
TR199801919T2 (xx) Rapamisin t�revlerinin damar hastal�klar� ve yabanc� doku naklinde kullan�m�.
NO951432D0 (no) Farmasöytiske preparater
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
ATE218320T1 (de) Kombinationen von vasoaktiven stoffen mit fettsäuren zur verhütung von haarausfall
ES2149776T3 (es) Modulacion, inducida por un morfogeno, de la respuesta inflamatoria.
ES2064119T3 (es) Nuevos derivados de aminobenzosultam como inhibidores de la lipoxigenasa.
DE69306559D1 (de) Neue kardioprotektive wirkstoffe
JPS5714517A (en) Whitening cosmetic
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ES2110602T3 (es) Nuevos derivados de 2,3-dihidro-2,2,4,6,7-pentaalquil-5-benzofuranoles.
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
ITBO920160A1 (it) Composizione e procedimento per il trattamento dei tessuti
DE68904195D1 (de) Paromomycin oder seine derivate zur parenteralen behandlung von parasitaeren erkrankungen beim menschen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: AVENTIS INC. (N.D.GES.D. STAATES PENNSYLVANIA), GR

8327 Change in the person/name/address of the patent owner

Owner name: AVENTISUB II INC., GREENVILLE, DEL., US